Robotic Surgery for Early-Stage Lung Cancer
Part of Cancer, Lungs & breathing clinical trials.
This study is testing a new robotic surgical system for removing lung cancer in its early stage. It aims to see if the technique is safe and effective for people with stage I non-small cell lung cancer who need a lobectomy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosis of non-small cell lung cancer (NSCLC)
- Clinical stage I disease (according to 9th TNM edition)
- Planned or completed lobectomy with radical lymph node dissection
- Willingness to participate and provide consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether robotic-assisted surgery for lung cancer is safe and effective in elderly patients. It may be a good option if you are older and able to undergo surgery.
This study compares two types of minimally invasive surgery—robotic-assisted (da Vinci) and VATS—for people with early-stage non-small cell lung cancer. The goal is to see which approach might work better and help patients recover faster.
This trial compares two minimally invasive surgeries for early-stage non-small cell lung cancer: robotic-assisted (RATS) versus video-assisted (VATS). It aims to see which approach is better for removing a lobe or part of a lobe, focusing on recovery and safety.
This trial studies a new surgical robot that uses only one small opening in the chest to remove a lung segment or lobe. It aims to see if the robot is safe and effective for patients who need this type of surgery.
This trial compares two types of robot-assisted lung surgery for early-stage non-small cell lung cancer. One method uses a fully robotic setup, and the other involves the surgeon helping with part of the procedure. The goal is to see which approach works better for patients.
This trial compares robot-assisted surgery to video-assisted surgery for removing lung cancer. It aims to see which approach works better for patients with early-stage non-small cell lung cancer.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.